| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc5256be365101d0394467d78ffce395 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 |
| filingDate |
2001-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1bc0c72c2ee4ea322d4d93176f9ee44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c7f54ea7bb7974aad180670a15315bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe9ad047413afa20582f47c8dc603e60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38c7fd4ea69d4ab9e69816537ce95492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c24da305d39ded9fadc6f8d268ce23e |
| publicationDate |
2004-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1291349-B1 |
| titleOfInvention |
Malto-oligosaccharide derivatives and use thereof |
| abstract |
The present invention provides a substance which strongly inhibits human alpha -amylase and is effective for the prevention and treatment of hyperglycemia, for example, diabetes and the diseases caused thereby, and an alpha -amylase inhibitor and a prophylactic or therapeutic agent for hyperglycemia containing the said substance as active principle. Maltoligosaccharide derivatives represented by the following formula: <CHEM> (wherein n is an integer of 0 to 2; m is an integer of 0 to 2; and X represents a hydrogen atom or a hydrophobic group) or their hydrates or physiologically acceptable salts are provided, and they are contained as active principle to prepare an alpha -amylase inhibitor and a prophylactic or therapeutic agent for hyperglycemia such as diabetes. <IMAGE> |
| priorityDate |
2000-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |